Vida Health, a leading provider of virtual cardiometabolic care services, announced today that it has raised $28.5 million in a financing round led by existing investors.
The company also announced that Joe Murad, a veteran healthcare technology executive, has joined as the new CEO, succeeding the founder Stephanie Tilenius, who will transition to an advisory role.
Vida plans to use the funds to scale its business and pursue growth opportunities, especially in the fast-growing GLP-1 market, where it offers a unique combination of behavioral and prescriptive therapies for patients with cardiometabolic conditions, such as diabetes and heart disease. Vida claims to be the first solution to combine behavior change with GLP-1 prescribing, a market that is expected to reach $100 billion by 2030.
Murad has over 20 years of experience leading healthcare technology companies, including WithMe Health, PokitDok, and Extend Health. He said he is passionate about advancing Vida’s mission and leading the company through its next phase of growth.
Tilenius, who founded Vida in 2014, said she is proud of the company’s achievements and confident in Murad’s ability to take Vida to the next level. Matt Levin, Executive Chair of the Vida Board of Directors, thanked Tilenius for her contributions and welcomed Murad as the new leader.